Skip to content

PTSD: all studies

Page 52 of 210: studies 511 to 520 of 2,096, newest first. Back to the PTSD overview

Research

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Psychopharmacology September 1, 2019 Michael C Mithoefer, Allison A. Feduccia, Lisa Jerome et al. 364 citations Retracted

Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Here we evaluate six phase 2 trials in a pooled analysis to determine the study design for phase 3 trials of MDMA-assisted psychotherapy for PTSD. Six randomized, double-blind, controlled clinical trials at five study sites were conducted...

DOI: 10.1007/s00213-019-05249-5 (opens in new tab) Full text (opens in new tab) MDMA-Assisted Psychotherapy Posttraumatic stress disorder MDMA Alongside Therapy Active MDMA +7

Culturally informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder

Journal of Psychedelic Studies July 30, 2019 Monnica T. Williams, Sara Reed, Ritika Aggarwal 87 citations

Recent research suggests that psychedelic drugs can be powerful agents of change when utilized in conjunction with psychotherapy. Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy has been studied as a means of helping people overcome posttraumatic stress disorder, believed to work by reducing fear of traumatic memories and increasing feelings of trust and compassion toward others,...

Translating Molecular and Neuroendocrine Findings in PTSD and Resilience to Novel Therapies

Biological Psychiatry July 24, 2019 J. DePierro, Lauren Lepow, Adriana Feder et al.

Many biological systems are altered in association with Posttraumatic Stress Disorder (PTSD) and resilience. However, there are only few approved pharmacological treatments for PTSD, and no approved medications to enhance resilience. This paper provides a critical review of select neurobiological findings in PTSD and resilience, and also of pharmacologic approaches that have emerged from this...

Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD

The Family Journal July 1, 2019 Katie Almond, Robert Allan 7 citations

This article explores incorporating 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct in emotionally focused couples therapy (EFT) with clients in which at least one participant has endured a traumatic experience and reports symptoms of post-traumatic stress disorder (PTSD). Despite classification as a Schedule I drug on the Controlled Substances Act (CSA), in 2017 the U.S. Food and Drug...

Mindfulness training reduces PTSD symptoms and other stress-related health outcomes in police officers

June 11, 2019 Daniel W Grupe, Chad Mcgehee, Christine E. Smith et al.

BACKGROUND. Police officers are exposed daily to high levels of organizational and operational stressors that have a negative impact on health and well-being outcomes. This population has elevated rates of cardiovascular disease, sleep disorders, symptoms of depression and post-traumatic stress disorder (PTSD), and suicide. Although there are few empirically supported effective stress reduction...

Study protocol for a non-inferiority randomised controlled trial of SKY breathing meditation versus cognitive processing therapy for PTSD among veterans.

BMJ Open April 3, 2019 Danielle C Mathersul, Julia S Tang, R Jay Schulz-Heik et al.

Post-traumatic stress disorder (PTSD) is a debilitating, highly prevalent condition. Current clinical practice guidelines recommend trauma-focused psychotherapy (eg, cognitive processing therapy; CPT) as the first-line treatment for PTSD. However, while these treatments show clinically meaningful symptom improvement, the majority of those who begin treatment retain a diagnosis of PTSD...

Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder.

Behavioural Pharmacology April 1, 2019 Kevin Sean Murnane 84 citations

Serotonin, one of the first neurotransmitters to be identified, is an evolutionarily old molecule that is highly conserved across the animal kingdom, and widely used throughout the brain. Despite this, ascribing a specific set of functions to brain serotonin and its receptors has been difficult and controversial. The 2A subtype of serotonin receptors (5-HT2A receptor) is the major excitatory...

Compassion Meditation for Posttraumatic Stress Disorder in Veterans: A Randomized Proof of Concept Study

Journal of Traumatic Stress March 31, 2019 Ariel J Lang, Anne Malaktaris, Pollyanna Casmar et al. 50 citations

There is considerable interest in developing complementary and integrative approaches for ameliorating posttraumatic stress disorder (PTSD). Compassion meditation (CM) and loving-kindness meditation appear to offer benefits to individuals with PTSD, including symptom reduction. The present study was a pilot randomized controlled trial of CM for PTSD in veterans. The CM condition, an adaptation...

Sleep disturbances and nightmares in victims of sexual abuse with post-traumatic stress disorder: an analysis of abuse-related characteristics.

European Journal of Psychotraumatology March 21, 2019 Geneviève Belleville, Mylène Dubé-Frenette, Andréanne Rousseau

Background: Sexual abuse victims often experience symptoms of post-traumatic stress disorder (PTSD), including sleep disturbances. Objective: To investigate whether or not characteristics of sexual abuse are associated with sleep disturbance, and to explore whether correlates of sleep disturbance are distinguishable from those of PTSD symptom severity. Method: Forty-four adult sexual abuse...

Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD

Journal of Psychoactive Drugs March 8, 2019 William P. Barone, Jerome Beck, Michiko Mitsunaga-Whitten et al. 63 citations

We present select findings from a long-term follow-up qualitative study of MDMA-assisted psychotherapy for veterans, firefighters, and police officers suffering from chronic, treatment-resistant PTSD. Semi-structured qualitative interviews were conducted at participants' one-year follow-up after a recently completed phase 2 clinical trial. Available interviews from 19 of 24 participants were...

DOI: 10.1080/02791072.2019.1580805 (opens in new tab) MDMA Thematic analysis Qualitative research Interpretative phenomenological analysis +4